Activity Report for 2011-2012 17/11/20121. 2 During last year, it was stated that: There had been a strong effort of the president, Dr Gérard Nguyen,

Slides:



Advertisements
Similar presentations
6th European Patients’ Rights Day The EMA Geriatric Medicines Strategy and the empowered aging patient Francesca Cerreta EMA (European Medicines Agency)
Advertisements

¨ Dr Alain Garcia General Secretary of the Rare Diseases National Plan The second National Plan for Rare Diseases in France
Communication, Exchange and dissemination of good practices.
Promoting patient-centred healthcare around the world A patient perspective on the multiple policy initiatives: Lessons learnt – assessing the gaps Joanna.
The World Federation of Colleges and Polytechnics (WFCP): An engaging force World Federation of Colleges and Polytechnics Yannick Cabassu Member Engagement.
SPANISH ASSOCIATION OF ATAXIA PATIENTS FEDAES  In 1998, we generated the ing list of Hispataxia and the webpage.  In 2000, we contacted researchers.
Audit Committee and Corporate Governance. The European Confederation of Institutes of Internal Auditing (ECIIA) Founded in 1982 Confederation of 32 countries.
Eurordis.org EURORDIS – hvad går det ud på? v. Birthe Byskov Holm, formand Sjældne Diagnoser 1.
30 years of ADI Three decades of global collaboration ADI established in October 1984, grown from 4 to over 80 member associations Photo gallery online:
European Platform of Women Scientists Brussels, October 12th, 2007 NEWS Founding Meeting Dr. Marianne Schwarz da Silva.
Project part financed by the European Union (European Development Fund) within the Interreg IIIC programme European Cultural Tourism Network Presentation.
A STRONG PATIENTS’ VOICE TO DRIVE BETTER HEALTH IN EUROPE EPF Annual General Meeting 19 May 2010 EPF Annual General Meeting 19 May 2010.
European Fragile X Network Council of European Federations Paris, 14 & 15 October 2014 Synthesis for Berlin EFXN Berlin, November 8, 2014.
THE ROLE OF ALZHEIMER ASSOCIATIONS IN CAMPAIGNING FOR CHANGE Marc Wortmann Alzheimer’s Disease International.
3rd Baltic Conference on Medicines Economic Evaluation, Reimbursement and Rational Use of Pharmaceuticals Pricing and Reimbursement of Pharmaceuticals.
European Women ’ s Lobby Lobby Europ é en Des Femmes.
ACSM MEETING A Centre for Resource Mobilization by Louise Baker, Stop TB Secretariat.
Paediatric Palliative Care and Policy Development Dr Chantal Wood Chair EAPC Paediatric Taskforce National Health Ministry PPC Taskforce Head of the Paediatric.
National Platforms Effective tool for advocacy Agnese Knabe Project coordinator European Public Health Alliance Civic Alliance – Latvia 17 October, 2006,
Stroke helplineWebsite www.stroke.org.uk Stroke helplineWebsite www.stroke.org.uk.
Raleigh N.C., 22 – 24 July European update.
The Role of Patients in EU Policy Development European Health Forum Gastein October 2003 – Bad Gastein Presented by Erick Savoye Director of the European.
EURO-HSP General Assembly and Annual Meeting May 31 – June 1, 2015 Madrid, Spain Euro-HSP - GA May 31 / June 1 - Madrid, Spain 1.
Advocacy and policy dialogue at national level on development education Seminar for NGDO Platforms of New Member States Budapest, 9-10th March 2006 Rilli.
1 "Cancer and the European Citizen – it’s time to deliver! Francesco De Lorenzo ECPC President ECPC Members in Action Conference 2009 ALL CANCER PATIENTS.
Welcome to SURF 09 Involving Patients and the Public in HCAI Research.
ITUC Human and Trade Union Rights Report of the PERC HTUR Network Meeting PERC HTUR Network PERC Summer School, Bratislava September
Promoting patient-centred healthcare around the world Patient-Centred Healthcare: A Global Concern Jo Harkness, Policy & External Affairs Director, IAPO.
EFHSP First things first. Rare!Together PRO’s Contact between people from different countries and various cultural backgrounds sharing the same special.
WFD, Common Implementation Strategy Water Scarcity and Droughts Expert Group Madrid, February 17, 2010.
> February 2010 Kick-Off meeting - Lilongwe WP: Build-up of Cooperative Network – EU and Africa Kenneth Matengu and Pempelani Mufune.
GCR Board of Directors 10-JUN DRAFT Board of Directors Roles and Responsibilities Purpose/Agenda Purpose Define Board of Directors Role Responsibilities.
The Maruzza Lefebvre D’Ovidio Foundation Silvia Lefebvre D’Ovidio.
European Public Health Association – EUPHA And the future of public health in Europe Marieke van der Waal Dineke Zeegers Paget.
ESID juniors ESID Juniors WP-Proposal Prague, May Eleonora Gambineri (head of ESID Junior WP) & Ales Janda.
LEONARDO TRANSFER OF INNOVATION PROJECT “MEDIA TECH: The future of media industry using innovative technologies ” No. LLP-LdV-ToI-11-CY Kick-off.
PATIENT-CENTERED OUTCOMES RESEARCH INSTITUTE PCORI Board of Governors Meeting Washington, DC September 24, 2012 Anne Beal, MD, MPH, Chief Operating Officer.
KIDS GEORGIA (Kids and Families Impacting Disease through Science) Child Life Department: June 17 th, 2015.
Collaboration – leads us for better result Agnese Knabe Project coordinator European Public Health Alliance Civic Alliance – Latvia 2-3 June, 2006, Legnica,
Orientation for new Lead Partners and Partners Information & Publicity Requirements Lead Partner and Partner Seminar 12 June 2008 – Voss, Norway Kirsti.
How to Plan a Successful Academic Year with Your Chapter: Keeping the End in Mind JODI BROOKINS-FISHER, PHD, MCHES ESG PRESIDENT HOLLY TURNER MOSES, PHD,
‘LINKING MEMBERS’ Towards a new phase in Eurocarers’development Henk Bakkerode Brussels, 16 November 2010.
Taiwanese Society Committees Election 2/12/2014 EGM.
EN Regional Policy EUROPEAN COMMISSION Upcoming events and news, Communication actions, success stories, evaluation, OPEN DAYS 2006 SFIT, 15 June 2006.
EARIP- European Asthma Research and Innovation Partnership Dr Samantha Walker (Asthma UK) “Does innovative research for allergy and respiratory disease.
EUPATI Training Course Patient Experts in Medicines Research & Development The project is receiving support from the Innovative Medicines Initiative Joint.
Slide 1 The contribution of a world-class regulatory environment to the future of the industry in Ireland Pat O’Mahony Chief Executive, Irish Medicines.
European Patients’ Academy on Therapeutic Innovation – The project is receiving support from the.
CFOA Change Programme.
Round-table discussion Session 4 Aime, Eugenijus and Asta
Update of the Scientific Secretariat
General Assembly and Annual Meeting June 25 – 26, 2016 Paris, France
Euro-HSP - GA 2017 – June 17 – 18 - Alghero, Sardinia
Association for Teacher Education in Europe
Support- IRDiRC Proposed Work Plan And Communication Strategy
Experiences of the Association of European Election Officials as ACE Regional Centre Overview First part of 2009 Stockholm, Sweden, June 2009.
International Conference “National Rural Development Network – Joining the Activities for the economic and Social Rural Development“   September 21.
African Regional Meeting on 4-5 July 2017 in Entebbe, Uganda
Paediatric Working Group
HPH Strategy Seminar Beijing, China 7 september 2013 Andrea Limbourg
Organization of Arab Electoral Management Bodies (ArabEMBs)
Activity Report Copenhagen – 26/10/2018
RSE Annual General Assembly
Cancer Symptom Trials (CST) Membership
WFD, Common Implementation Strategy  Water Scarcity and Droughts Expert Group Madrid, February 17, 2010.
BID Expansions Wiri Creating a United Business Precinct
European Association of Thermology
An Overview of the Post-Graduate Education and Training Program
Cancer Symptom Trials (CST) Membership
Presentation transcript:

Activity Report for /11/20121

2 During last year, it was stated that: There had been a strong effort of the president, Dr Gérard Nguyen, to make RSE known by the European institutions: EURORDIS, EMA, EUCERD … But the network had to be revitalised and a strong effort was needed in that prospect

17/11/20123 A new board was elected with a new president and a new secretary Emmett Harten (Irish association) Martine Gaudy But the president resigned after a few months, only 4 members of the board: Martine Gaudy (France) Lorna Jaffa (UK) Oliveiro Del’Orro (Italy) Thomas Bertrand (France)

17/11/20124 Suggestions from members during GA of NOV 2011 which would revitalise the association (see 14 of minutes) Revisit statutes to assess our aims – get back to basics Improve communication: Update website Ensure that the Annual General Assembly is a properly organised meeting with enough time for debate and socialising to revitalise the contacts between members Reinstate the social aspect of RSE. This will enable us to exchange informations and get to know each other

17/11/20125 Try to recreate links with countries where communication was lost Improve support to families Explore partnerships with other similar conditions e.g. Angelman’s syndrome Does someone in RSE need to co-ordinate foreign projects? How do we support women with Rett syndrome? Strengthen RSE. Keep European research money in Europe. We need to add value to national associations Reports from national associations to be ed to minutes secretary before the next meeting

Our Achievements AIM 1 of the statutes: improve the communication within the European Rett Community 1.Revitalise the network – Updating all the contacts in all countries to be able to communicate – Help from Danijela for Eastern Europe 17/11/20126

7 Our Achievements: Building the Network 2. Build a new website Renewal of the website, keep the idea of a European map with all countries and links to their website and contacts of national associations when strolling on the country Please each country check your details

17/11/20128 Our Achievements: Building the Network 3. New logo, hands with the stars of Europe on a blue color. Logo « member of RSE » for associations that have paid their fee 4. Build a social network: RareConnect Owing to Eurordis support, we have developed a social network for RTT – Thomas Bertrand

17/11/20129 Our Achievements: External Influence and Advocacy AIM 2 of the statutes: to promote as a representative European Organisation, the interests of people with RTT and families Having RSE officially in the network of European institutions 1.We became officially member of EURORDIS: allows us to vote at the GA of EURORDIS and the ECRD (European Conference on RD) Thomas and Danijela in Brussels

Our Achievements: External Influence and Advocacy 2. Working groups of Eurordis:  Summer School June on « patient advocates in clinical trials and drug development » July 2012, Barcelona, Danijela  Task Forces: DITA Drug Information and Transparency Access Task Force September 2012, Danijela 3. EUCERD: European Union Committee of Experts in Rare Diseases, G. Nguyen 17/11/201210

Our Achievements: External Influence and Advocacy 4. EMA European Medicine Agency: RSE fulfils the criteria to be involved (letter of 14/11/11)  Working groups of EMA in London: Pharmacovigilance Workshop Feb 2012, Danijela  PCWP: Patient and Consumer Working Group Feb 2012, Danijela  PDCO: Pediatrics Committee 17/11/201211

Our Achievements: External Influence and Advocacy 5. DIA: Drug Information Association - Annual Euromeeting March 2012, G. Nguyen and Danijela, Copenhagen 6. EUPATI: European Patients Academy on Therapeutic Innovation - Workshop Sept 2012, Danijela, Frankfurt 17/11/201212

Our Achievements RSE at the 7th WRSC World Rett Syndrome Congress Thomas and Martine present at the WRSC in New Orleans June 2012 On behalf of RSE address during the Family Reception 17/11/201213

Our Achievements RSE Publications 2 posters were presented at the ECRD and WRSC and accepted by the scientific committee: E-Patient and Modelling Family Outcomes 1 poster accepted for the BCPS, International Conference for Behavioural, Cognitive and Psychological Sciences in Bangkok 17/11/201214

Our Achievements AIM 3: Expand RSE to all European Countries and assist if necessary in the creation of national associations In september 2012, the Russian association held a family meeting. France and Finland attended and supported Contacts made with Iceland 4 RTT girls 17/11/201215

Challenges and questions How to make the RSE network live? How to develop the website even more? What kind of informations members would like to find? Rareconnect and other social media to develop? What should be the role of RSE? Problems of funding? Fundraising? Role in advocating for research and/or care issues? 17/11/201216